Capsaicinoids Enhance Metabolic Rate – An Open Label Study

Capsaicinoids Enhance Metabolic Rate Using a Novel Metabolic Tracker Breezing Device – An Open Label Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13980309

Enrollment

Registered

2016-12-15

Start date

2016-05-10

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolism Nutritional, Metabolic, Endocrine Metabolism

Interventions

Participants are randomised to one of two groups who receive two treatments in a random order. Group 1: Participants receive 100 mg Capsimax (Capsaicinoids 2 mg) once a day with a meal single adminis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. English-speaking 2. Adult participants (18 – 80 years old) 3. Sedentary or lightly active lifestyle 4. Able to consent and perform the necessary tests for the study

Exclusion criteria

Exclusion criteria: 1. Food allergy or sensitive to gluten 2. Under treatment for chronic conditions/disease such as cancer, burns or obstructive pulmonary diseases

Design outcomes

Primary

Measure	Time frame
Resting Energy Expenditure (Metabolic rate) is measured using breezing equipment (indirect calorimetry) at baseline, 1 hour, 2 hours and 3 hours and data calculated for 24 hours (overall average ?REE%). ?REE: REEi – REE0 ?REE (%) : [(REEi – REE0)/REE0] *100%	—

Secondary

Measure	Time frame
1. Heart rate measured using i-phone apps and blood pressure are measured using with sphygmomanometer at baseline and after 3 hours 2. Appetite and interest on food intake is measured using a visual analogue scale (0-100 scale) at baseline and at 3 hours	—

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026